Journals / Türk Kardiyoloji Derneği Arşivi / 2019 / Cilt: 47 - Sayı: 3

Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR

Snapshot evaluation of heart failure in Turkey: Türkiye’de kalp yetersizliğinin anlık görüntüsü: SELFIE-TR bazal karakteristik özellikleri

Pages
198–206
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patients with chronic HF were younger than those with acute HF (61.1±13.3 years vs 67.9±12.1 years; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Heart failure (HF) is an important health issue of the 21st century and the prevalence in Turkey has been reported as 2.9%.
📊
Key Findings & Data:Methods: A total of 23 centers with at least 2 cardiologists from the 12 NUTS-1 regions of Turkey were invited to participate in the research.
💡
Conclusion & Impact:The patients with chronic HF were younger than those with acute HF (61.1±13.3 years vs 67.9±12.1 years; p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Heart failure (HF) is an important health issue of the 21st century and the prevalence in Turkey has been reported as 2.9%. A national profile, frequency data, characteristics of different phenotypes, and risk factors have not yet been well established. The Snapshot Evaluation of Heart Failure Patients in Turkey (SELFIE-TR) was an analysis of a representative sample of HF patients from Turkey. Methods: A total of 23 centers with at least 2 cardiologists from the 12 NUTS-1 regions of Turkey were invited to participate in the research. The contributing centers shared the data of a consecutive enrollment of HF patients, as confirmed by an investigator, on a pre-selected day of each week for the month of October or November of 2015. Results: The mean age of the entire cohort was 63.3±13.3 years (male/female ratio: 751/303, 71.3%/28.7%). There were 712 acute HF patients and 342 chronic HF patients. The total number of HF patients with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction, and heart failure with preserved ejection fraction was 801 (75%), 176 (16.7%), and 77 (7.3%), respectively. The patients with chronic HF were younger than those with acute HF (61.1±13.3 years vs 67.9±12.1 years; p

Özet

Amaç: Kalp yetersizliği (KY) 21. yüzyılın önemli bir sağlıksorunudur ve ülkemizdeki sıklığı %2.9’dur. Bu hastalığınülke profili, farklı fenotiplerin sıklığı ve özellikleri, risk faktörlerinet olarak ortaya konulmamıştır. Bu çalışmada, ülkemizitemsil eden bir örnekte KY hastaları (SELFIE-TR – SnapshotEvaluation of Heart Failure Patients in Turkey) incelenmiştir.Yöntemler: Ülkemizdeki 12 NUTS-1 bölgesinden en az ikikardiyoloji uzmanının çalıştığı 23 merkez çalışmaya davetedildi. Merkezler, Ekim veya Kasım aylarından tercihettiği bir tanesinde, tercih edilen ay içindeki 4 haftanın yinetercih edilen bir gününde, tanısı kılavuzlara uygun olarakdoğrulanmış KY hastalarını ardışık olarak çalışmaya dahilettiler.Bulgular: Tüm grubun (n=1054) yaş ortalaması 63.3±13.3yıl idi (E/K oranı: 751/303, %71.3/%28.7). Tüm kohortta kronikKY/akut KY hasta sayıları sırasıyla 712 ve 342; düşükejeksiyon fraksiyonlu KY (DEF-KY), sınırda ejeksiyon fraksiyonluKY (SEF-KY) ve korunmuş ejeksiyon fraksiyonlu KY(KEF-KY) hasta sayıları sırasıyla 801 (%76), 176 (%16.7), 77(%7.3) olarak tespit edildi. Kronik KY olan hastalar akut KYolan hastalara göre daha gençti (61.1±13.3 yıl ve 67.9±12.1yıl, p

🔖

Cite This Article

Zoghi, M., Onrat, E., Güngör, H., Bekar, L., Kılıçaslan, B., Akdemir, R., Yalta, K., Kutlu, M., Temizhan, A., Eren, M., Çelik, A., Tokgozoglu, L., Demir, M., Çavuşoğlu, Y., Yılmaz, M. B. (2022). Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR. Türk Kardiyoloji Derneği Arşivi, Cilt: 47 - Sayı: 3, 198–206. https://ajindex.com/articles/632045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Değertekin M, Erol C, Ergene O, Tokgözoğlu L, Aksoy M, Erol MK, et al. [Article in Turkish] [Heart failure prevalence and predictors in Turkey: HAPPY study]. Turk Kardiyol Dern Ars 2012;40:298−308
  2. Tokgözoğlu L, Kayıkçıoğlu M, Altay S, Aydoğdu S, Barçın C, Bostan C, et al. [Article in Turkish]. [EUROASPIREIV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronaryartery disease: Data from Turkey]. Turk Kardiyol Dern Ars 2017;45:134−44
  3. Zoghi M, Kaya H, Çavuşoğlu Y, Aksakal E, Demir Ş, Yücel C, et al. Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fractionpatients: The Beta GenTURK study. Turk Kardiyol Dern Ars 2016;44:457−65
  4. Taş B. AB Uyum Sürecinde Türkiye için Yeni bir Bölge Kavramı: İstatistiki Bölge Birimleri Sınıflandırması (İBBS), Afyon Kocatepe Üniversitesi Sosyal Bilimler Enstitüsü Dergisi 2006;8:2. s. 187−9
  5. Aras D, Aydoğdu S, Bozkurt E, Çavuşoğlu Y, Eren M, Erol Ç, et al. Cost of heart failure management in Turkey: results of a Delphi Panel. Anatol J Cardiol 2016;16:554−62
  6. Kaya H, Beton O, Acar G, Temizhan A, Cavusoğlu Y, Guray U, et al. Influence of influenza vaccination on recurrent hospitalization in patients with heart failure. Herz 2017;42:307−15
  7. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147−239
  8. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatmentof acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891−975
  9. Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObservational Research Programme: the Heart Failure PilotSurvey (ESC-HF Pilot). Eur J Heart Fail 2010;12:1076−84
  10. Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-